<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03118245</url>
  </required_header>
  <id_info>
    <org_study_id>H1704-083-846</org_study_id>
    <nct_id>NCT03118245</nct_id>
  </id_info>
  <brief_title>Ambu AuraGain Laryngeal Mask Airway and I-gel in Children</brief_title>
  <official_title>A Randomized Comparison of Ambu AuraGain (Original Name of Product) Laryngeal Mask Airway and I-gel in Children</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Children aged below 7 years are randomly assigned to AuraGain Group or I-gel group. After
      anesthetic induction, AuraGain or I-gel is inserted and mechanical ventilation is started.
      Oropharyngeal leak pressure, peak inspiratory pressure, success rate for insertion, ease for
      insertion, ease for gastric tube insertion and fiberoptic bronchoscopic views will be
      compared between two groups.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 12, 2017</start_date>
  <completion_date type="Anticipated">May 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Device Feasibility</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Oropharyngeal leak pressure</measure>
    <time_frame>30 seconds after AuraGain or I-gel insertion</time_frame>
    <description>The airway pressure at which a leak sound is detected around the patient's mouth and at which the airway pressure has reached equilibrium, when the pressure-limiting valve of the anesthesia breathing system is closed and the fresh gas flow rate is fixed at 3 liter/min</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Peak inspiratory pressure</measure>
    <time_frame>through study completion, an average of 1 hour</time_frame>
    <description>Peak airway pressure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Success rate</measure>
    <time_frame>Within 5 minutes after anesthetic induction</time_frame>
    <description>Success rate of AuraGain or I-gel insertion</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ease of AuraGain or I-gel insertion</measure>
    <time_frame>Within 5 minutes after anesthetic induction</time_frame>
    <description>1. No resistance 2. Moderate resistance 3. High resistance 4. Inability to pass</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Ease of gastric tube insertion</measure>
    <time_frame>Within 5 minutes after anesthetic induction</time_frame>
    <description>1. Easy 2. Difficult 3. Unable to pass</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>fiberoptic bronchoscopic veiw</measure>
    <time_frame>Within 10 minutes after anesthetic induction</time_frame>
    <description>1. No visible glottis 2. Visible glottis and anterior epiglottis 3. Visible glottis and posterior epiglottis 4. Only glottis is visible</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">88</enrollment>
  <condition>General Anesthesia</condition>
  <arm_group>
    <arm_group_label>AuraGain group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>AuraGain is inserted for maintenance of general anesthesia. The size 1 is for children &lt;5kg, size 2 for 5-10kg, size 2 for 10-20kg, and size 2.5 for 20-30kg.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>I-gel group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>I-gel is s inserted for maintenance of general anesthesia. The size 1 is for children weighted 2-5kg, size 2 for 5-12kg, size 2 for 10-25kg, and size 2.5 for 25-35kg.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>AuraGain</intervention_name>
    <description>After anesthetic induction, AuraGain is inserted in children</description>
    <arm_group_label>AuraGain group</arm_group_label>
    <other_name>Ambu AuraGain</other_name>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>I-gel</intervention_name>
    <description>After anesthetic induction, I-gel is inserted in children</description>
    <arm_group_label>I-gel group</arm_group_label>
    <other_name>I-gel supraglottic airway</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Children &lt; 7 years old who scheduled for general anesthesia using supraglottic airway

        Exclusion Criteria:

          -  Children who require tracheal intubation

          -  Emergency operation without nil per os

          -  History of C-spine surgery or disease

          -  History of Esophageal disease or surgery
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>7 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jin-Tae Kim, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jin-Tae Kim, PhD</last_name>
    <phone>+82-2-2072-3592</phone>
    <email>jintae73@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jin-Tae Kim, MD. PhD.</last_name>
      <phone>82-2-2072-3664</phone>
      <email>kimjintae73@dreamwiz.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 9, 2017</study_first_submitted>
  <study_first_submitted_qc>April 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 18, 2017</study_first_posted>
  <last_update_submitted>June 15, 2017</last_update_submitted>
  <last_update_submitted_qc>June 15, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 16, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jin-Tae Kim</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

